Organization
Alara Medical Group
7 abstracts
Abstract
7+3 versus decitabine + venetoclax: A global, propensity-matched study comparing outcomes for both regimens in AML.Org: Alara Medical Group,
Abstract
Radical prostatectomy versus XRT for early-stage prostate cancer: A retrospective, propensity-matched cohort study of 29,970 patients.Org: Baylor University Medical Center, Alara Medical Group,
Abstract
Chemoradiation versus cystectomy for locally advanced bladder cancer: A global, propensity-matched retrospective cohort study.Org: Alara Medical Group, Baylor University Medical Center,
Abstract
Vitamin D deficiency as a risk factor for breast cancer development.Org: Alara Medical Group, University of Texas Medical Branch at Galveston, Department of Biochemistry and Molecular Biology, University of Texas Medical Branch,
Abstract
The adjuvant oxaliplatin-irinotecan paradox.Org: Alara Medical Group, University of Texas Medical Branch at Galveston, UTMB Health,
Abstract
Apixaban versus rivaroxaban for treatment of acute deep venous thrombosis in patients with cancer.Org: Department of Biochemistry and Molecular Biology, University of Texas Medical Branch at Galveston, Alara Medical Group,
Abstract
Transcatheter-directed Y-90 radioembolization compared with chemoembolization for the treatment of hepatic metastases from colon cancer.Org: University of Texas Medical Branch at Galveston, Department of Biochemistry and Molecular Biology, Alara Medical Group,